SCHEMBL7841351

SCHEMBL7841351

CC(=O)c1ccc(C(=O)OC(=O)c2ccc(C(C)=O)c3ccccc23)c2ccccc12

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.46
BRD4 O60885 2/20 0.46
ALDH1A1 P00352 2/20 0.46
HPGD P15428 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
GAA P10253 2/20 0.44
TSHR P16473 2/20 0.44
MAPT P10636 3/20 0.44
KMT2A Q03164 3/20 0.44
PBRM1 Q86U86 1/20 0.44
MEN1 O00255 1/20 0.44
NSD2 O96028 1/20 0.44
POLB P06746 1/20 0.44
MCL1 Q07820 1/20 0.44
AKR1C4 P17516 1/20 0.42
AKR1C3 P42330 1/20 0.42
AKR1C2 P52895 1/20 0.42
AKR1C1 Q04828 1/20 0.42
CREBBP Q92793 1/20 0.41
PLK1 P53350 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL38471077 0.87 KDM4E (0.55) KDM4EBRD4ALDH1A1HPGDL3MBTL1
SCHEMBL10391045 0.87 KDM4E (0.55) KDM4EBRD4ALDH1A1HPGDL3MBTL1
SCHEMBL982076 0.86 BRD4 (0.53) KDM4EBRD4ALDH1A1HPGDTSHR
SCHEMBL31049726 0.86 BRD4 (0.53) KDM4EBRD4ALDH1A1HPGDTSHR
SCHEMBL31049722 0.86 BRD4 (0.53) KDM4EBRD4ALDH1A1HPGDTSHR
SCHEMBL28416763 0.81 TSHR (0.63) KDM4EALDH1A1GAATSHRPOLB
SCHEMBL31284375 0.81 NR4A1 (0.52) KDM4EALDH1A1HPGDL3MBTL1TSHR
SCHEMBL9166724 0.79 IDO1 (0.54) KDM4EGAATSHRMAPTKMT2A
SCHEMBL982547 0.78 NR4A1 (0.54) KDM4EBRD4ALDH1A1HPGDL3MBTL1
SCHEMBL31396473 0.78 NR4A1 (0.54) KDM4EBRD4ALDH1A1HPGDL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6288232-B2 REACTION OF ACETYLNAPHTHALIC ANHYDRIDE AND ALDEHYDE IN THE PRESENCE OF AQUEOUS BASE AND BOILING IN THE PRESENCE OF ANILINE COMPOUND EMAGIN CORPORATION 2001-09-11 US claimed
US-20010012905-A1 Synthesis of pyrazolinylnaphthalic acid derivatives EMAGIN CORPORATION 2001-08-09 US claimed
US-6288232-B2 REACTION OF ACETYLNAPHTHALIC ANHYDRIDE AND ALDEHYDE IN THE PRESENCE OF AQUEOUS BASE AND BOILING IN THE PRESENCE OF ANILINE COMPOUND EMAGIN CORPORATION 2001-09-11 US disclosed
US-20010012905-A1 Synthesis of pyrazolinylnaphthalic acid derivatives EMAGIN CORPORATION 2001-08-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010012905-A1 Synthesis of pyrazolinylnaphthalic acid derivatives AHR, NAT1, ARSA KDM4E 3163/4885BRD4 1840/4885ALDH1A1 134/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.